Kacper Bluczak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kacper Bluczak has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandra StęPień
Medical University of Lublin, Poland al. Racławickie 1, 20-059 Lublin, Poland
6 shared publications - Kacper Bączek
University Clinical Centre, Gdansk, Poland
6 shared publications - Kacper Curzytek
University Clinical Hospital No. 1 in Lublin, Poland
6 shared publications - Karol Chromiak
Internship, 1st Military Clinical Hospital with the Outpatient Clinic, Lublin, Poland
6 shared publications - Marcelina Podleśna
Doctoral School, Medical University of Lublin, Poland
6 shared publications - Katarzyna Czechowicz
Stefan Cardinal Wyszyński Provincial Specialist Hospital SPZOZ in Lublin, Lublin, Poland
2 shared publications
Latest Publications
- Open Access
- 30 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (1(49))
ENDOTHELIAL DYSFUNCTION IN KAWASAKI DISEASE: FROM ACUTE INFLAMMATION TO LONG-TERM CARDIOVASCULAR SEQUELAE
Kawasaki disease primarily affects children under 5 years of age. Lesions primarily involve generalized inflammation of small and medium-sized vessels. Structural and functional changes in the coronary arteries make this disease the most common coronary artery disease in children. The disease involves destruction of the vascular endothelium, leading to remodeling and the formation of aneurysms, among other conditions. We are learning more and more about the factors causing this damage. Currently, inflammatory mediators, immune cells, and oxidative stress are involved in the pathogenesis of endothelial destruction. Pyroptosis, leading to the death of vascular endothelial cells, also appears to be important. Numerous genetic changes promoting these changes in non-coding miRNA sequences have also been described. There is a noticeable connection between changes occurring in the coronary vessels and subsequent cardiovascular incidents, especially when diseases such as hypercholesterolemia, diabetes and atherosclerosis occur. Because the disease was first described in 1967, data on its long-term effects are still being collected.
- 30 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (1(49))
Open AccessENDOTHELIAL DYSFUNCTION IN KAWASAKI DISEASE: FROM ACUTE INFLAMMATION TO LONG-TERM CARDIOVASCULAR SEQUELAE
Kawasaki disease primarily affects children under 5 years of age. Lesions primarily involve generalized inflammation of small and medium-sized vessels. Structural and functional changes in the coronary arteries make this disease the most common coronary artery disease in children. The disease involves destruction of the vascular endothelium, leading to remodeling and the formation of aneurysms, among other conditions. We are learning more and more about the factors causing this damage. Currently, inflammatory mediators, immune cells, and oxidative stress are involved in the pathogenesis of endothelial destruction. Pyroptosis, leading to the death of vascular endothelial cells, also appears to be important. Numerous genetic changes promoting these changes in non-coding miRNA sequences have also been described. There is a noticeable connection between changes occurring in the coronary vessels and subsequent cardiovascular incidents, especially when diseases such as hypercholesterolemia, diabetes and atherosclerosis occur. Because the disease was first described in 1967, data on its long-term effects are still being collected.
- Open Access
- 30 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (1(49))
THE ROLE OF GUT MICROBIOTA IN THE PATHOGENESIS OF POLYCYSTIC OVARY SYNDROME
Introduction and aim of the study: Polycystic ovary syndrome (PCOS) is a multifactorial endocrine–metabolic condition affecting a significant proportion of women of reproductive age. Recent scientific evidence suggests that disturbances in gut microbiota composition may play an important role in the metabolic, hormonal and inflammatory abnormalities characteristic of PCOS. The aim of this review was to summarize current knowledge on the relationship between gut microbiota and PCOS, with particular emphasis on pathophysiological mechanisms and potential therapeutic implications. Materials and Methods: This review was conducted through a systematic search of the PubMed database, using keywords related to PCOS, gut microbiota, dysbiosis, insulin resistance and hormonal imbalance. Relevant original research articles were analyzed to identify common mechanisms and clinically meaningful associations. Results: Findings indicate that gut dysbiosis in PCOS is closely linked to increased intestinal permeability, chronic low-grade inflammation, altered short-chain fatty acid (SCFA) production and disturbances in bile acid and tryptophan metabolism. These changes interact with key endocrine pathways regulating insulin sensitivity, androgen excess and estrogen conversion. Recent studies also highlight the therapeutic potential of dietary interventions, probiotics, prebiotics, synbiotics and bioactive nutrients, which can help restore microbial balance and improve metabolic and hormonal outcomes. Conclusions: Understanding the role of the gut microbiota in PCOS pathogenesis opens new perspectives for adjunctive therapeutic strategies. Microbiota-targeted interventions may provide meaningful support alongside conventional treatment, helping to address underlying mechanisms rather than only managing symptoms.
- 30 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (1(49))
Open AccessTHE ROLE OF GUT MICROBIOTA IN THE PATHOGENESIS OF POLYCYSTIC OVARY SYNDROME
Introduction and aim of the study: Polycystic ovary syndrome (PCOS) is a multifactorial endocrine–metabolic condition affecting a significant proportion of women of reproductive age. Recent scientific evidence suggests that disturbances in gut microbiota composition may play an important role in the metabolic, hormonal and inflammatory abnormalities characteristic of PCOS. The aim of this review was to summarize current knowledge on the relationship between gut microbiota and PCOS, with particular emphasis on pathophysiological mechanisms and potential therapeutic implications. Materials and Methods: This review was conducted through a systematic search of the PubMed database, using keywords related to PCOS, gut microbiota, dysbiosis, insulin resistance and hormonal imbalance. Relevant original research articles were analyzed to identify common mechanisms and clinically meaningful associations. Results: Findings indicate that gut dysbiosis in PCOS is closely linked to increased intestinal permeability, chronic low-grade inflammation, altered short-chain fatty acid (SCFA) production and disturbances in bile acid and tryptophan metabolism. These changes interact with key endocrine pathways regulating insulin sensitivity, androgen excess and estrogen conversion. Recent studies also highlight the therapeutic potential of dietary interventions, probiotics, prebiotics, synbiotics and bioactive nutrients, which can help restore microbial balance and improve metabolic and hormonal outcomes. Conclusions: Understanding the role of the gut microbiota in PCOS pathogenesis opens new perspectives for adjunctive therapeutic strategies. Microbiota-targeted interventions may provide meaningful support alongside conventional treatment, helping to address underlying mechanisms rather than only managing symptoms.
- Open Access
- 30 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (1(49))
LYME DISEASE AS A PUBLIC HEALTH CHALLENGE: A REVIEW OF RECENT EVIDENCE
Lyme disease, primarily caused by the spirochete Borrelia burgdorferi transmitted by ticks of the genus Ixodes, is a growing public health problem in many regions of the world. The disease is characterized by a diverse clinical course, including early skin lesions such as erythema migrans, and late joint, neurological, cardiac, and, less frequently, chronic complications. The pathogenesis of Lyme disease is associated with the invasion of tissues by the spirochetes and their ability to evade the host immune response, leading to chronic inflammation. Diagnosis relies on a combination of clinical assessment and serological testing, while considering the limitations of false positive and negative results. Standard treatment includes antibiotic therapy tailored to the stage of disease. Prevention plays a key role and includes the use of repellents, appropriate clothing, environmental monitoring, and public education and awareness in endemic areas. Effective prevention and early diagnosis are essential to reduce morbidity and clinical complications.
- 30 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (1(49))
Open AccessLYME DISEASE AS A PUBLIC HEALTH CHALLENGE: A REVIEW OF RECENT EVIDENCE
Lyme disease, primarily caused by the spirochete Borrelia burgdorferi transmitted by ticks of the genus Ixodes, is a growing public health problem in many regions of the world. The disease is characterized by a diverse clinical course, including early skin lesions such as erythema migrans, and late joint, neurological, cardiac, and, less frequently, chronic complications. The pathogenesis of Lyme disease is associated with the invasion of tissues by the spirochetes and their ability to evade the host immune response, leading to chronic inflammation. Diagnosis relies on a combination of clinical assessment and serological testing, while considering the limitations of false positive and negative results. Standard treatment includes antibiotic therapy tailored to the stage of disease. Prevention plays a key role and includes the use of repellents, appropriate clothing, environmental monitoring, and public education and awareness in endemic areas. Effective prevention and early diagnosis are essential to reduce morbidity and clinical complications.
- Open Access
- 23 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (1(49))
CLINICAL PRESENTATION OF LEFT VENTRICULAR NONCOMPACTION DIAGNOSED IN ADULTS
Left ventricular noncompaction (LVNC) is a rare, morphologically and genetically heterogeneous form of cardiomyopathy, the pathogenesis, classification, and clinical significance of which remain subjects of ongoing debate. The aim of this review is to present the current state of knowledge regarding the classification, pathophysiology, diagnostics, genetic determinants, clinical presentation, and therapeutic management of LVNC. The European Society of Cardiology (ESC) classifies LVNC as an unclassified cardiomyopathy, whereas the American Heart Association (AHA) considers it a genetically determined cardiac disorder. The characteristic morphology arises from abnormal compaction of the left ventricular trabeculae during embryogenesis, although an acquired or adaptive origin of these changes is also possible. Diagnostic evaluation relies primarily on echocardiography and cardiac magnetic resonance imaging; however, the lack of uniform morphological criteria contributes to both overdiagnosis and underdiagnosis. From a genetic perspective, sarcomeric gene mutations predominate and are associated with more severe clinical outcomes. Clinical manifestations include heart failure, arrhythmias, and thromboembolic complications, with reduced left ventricular ejection fraction being the principal prognostic factor. Therapeutic management follows general heart failure treatment strategies, thromboembolism prevention, and implantation of cardiac devices; in advanced cases, heart transplantation or mechanical circulatory support may be considered. An integrated diagnostic approach and the MOGE(S) classification system may serve as a foundation for future standardization.
- 23 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (1(49))
Open AccessCLINICAL PRESENTATION OF LEFT VENTRICULAR NONCOMPACTION DIAGNOSED IN ADULTS
Left ventricular noncompaction (LVNC) is a rare, morphologically and genetically heterogeneous form of cardiomyopathy, the pathogenesis, classification, and clinical significance of which remain subjects of ongoing debate. The aim of this review is to present the current state of knowledge regarding the classification, pathophysiology, diagnostics, genetic determinants, clinical presentation, and therapeutic management of LVNC. The European Society of Cardiology (ESC) classifies LVNC as an unclassified cardiomyopathy, whereas the American Heart Association (AHA) considers it a genetically determined cardiac disorder. The characteristic morphology arises from abnormal compaction of the left ventricular trabeculae during embryogenesis, although an acquired or adaptive origin of these changes is also possible. Diagnostic evaluation relies primarily on echocardiography and cardiac magnetic resonance imaging; however, the lack of uniform morphological criteria contributes to both overdiagnosis and underdiagnosis. From a genetic perspective, sarcomeric gene mutations predominate and are associated with more severe clinical outcomes. Clinical manifestations include heart failure, arrhythmias, and thromboembolic complications, with reduced left ventricular ejection fraction being the principal prognostic factor. Therapeutic management follows general heart failure treatment strategies, thromboembolism prevention, and implantation of cardiac devices; in advanced cases, heart transplantation or mechanical circulatory support may be considered. An integrated diagnostic approach and the MOGE(S) classification system may serve as a foundation for future standardization.
- Open Access
- 17 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (1(49))
INTERACTIONS BETWEEN IMMUNE CELLS, CARDIAC FIBROBLASTS, AND ENDOTHELIAL CELLS IN THE IMMUNE REGULATION OF CARDIAC FIBROSIS
Cardiac fibrosis is a central pathological feature of adverse myocardial remodeling and a key contributor to the development and progression of heart failure. Increasing evidence indicates that fibrosis is not a passive consequence of injury but a dynamic, regulated process driven by complex interactions between immune cells, fibroblasts, and endothelial compartments. The objective of this review is to synthesize current mechanistic insights into immune–stromal regulation of cardiac fibrosis, with particular emphasis on fibroblasts as central integrators of inflammatory, mechanical, metabolic, and vascular signals. This narrative review integrates findings from experimental, translational, and clinical studies addressing immune cell–fibroblast crosstalk, neutrophil extracellular trap formation, endothelial plasticity including endothelial-to-mesenchymal transition, and epigenetic and metabolic mechanisms that stabilize fibroblast activation. The literature was thematically analyzed to construct a unified conceptual framework rather than to perform a quantitative synthesis. The reviewed evidence highlights macrophage–fibroblast interactions as a dominant regulatory axis governing fibrotic remodeling, with distinct immune cell subsets exerting divergent effects on fibroblast activation and extracellular matrix deposition. Neutrophil extracellular traps and endothelial dysfunction further amplify profibrotic signaling, while epigenetic and metabolic reprogramming preserves activated fibroblast phenotypes beyond the acute injury phase. Circulating biomarkers of fibrosis reflect these underlying biological processes but capture remodeling dynamics rather than fixed fibrotic burden. In conclusion, cardiac fibrosis should be viewed as the outcome of regulated immune–stroma–endothelium communication rather than irreversible scarring. Targeting key interaction nodes within these networks may enable more precise strategies to limit pathological remodeling while preserving essential reparative responses.
- 17 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (1(49))
Open AccessINTERACTIONS BETWEEN IMMUNE CELLS, CARDIAC FIBROBLASTS, AND ENDOTHELIAL CELLS IN THE IMMUNE REGULATION OF CARDIAC FIBROSIS
Cardiac fibrosis is a central pathological feature of adverse myocardial remodeling and a key contributor to the development and progression of heart failure. Increasing evidence indicates that fibrosis is not a passive consequence of injury but a dynamic, regulated process driven by complex interactions between immune cells, fibroblasts, and endothelial compartments. The objective of this review is to synthesize current mechanistic insights into immune–stromal regulation of cardiac fibrosis, with particular emphasis on fibroblasts as central integrators of inflammatory, mechanical, metabolic, and vascular signals. This narrative review integrates findings from experimental, translational, and clinical studies addressing immune cell–fibroblast crosstalk, neutrophil extracellular trap formation, endothelial plasticity including endothelial-to-mesenchymal transition, and epigenetic and metabolic mechanisms that stabilize fibroblast activation. The literature was thematically analyzed to construct a unified conceptual framework rather than to perform a quantitative synthesis. The reviewed evidence highlights macrophage–fibroblast interactions as a dominant regulatory axis governing fibrotic remodeling, with distinct immune cell subsets exerting divergent effects on fibroblast activation and extracellular matrix deposition. Neutrophil extracellular traps and endothelial dysfunction further amplify profibrotic signaling, while epigenetic and metabolic reprogramming preserves activated fibroblast phenotypes beyond the acute injury phase. Circulating biomarkers of fibrosis reflect these underlying biological processes but capture remodeling dynamics rather than fixed fibrotic burden. In conclusion, cardiac fibrosis should be viewed as the outcome of regulated immune–stroma–endothelium communication rather than irreversible scarring. Targeting key interaction nodes within these networks may enable more precise strategies to limit pathological remodeling while preserving essential reparative responses.
- Open Access
- 24 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (4(48))
MAYER-ROKITANSKY-KÜSTER-HAUSER (MRKH) SYNDROME IN GIRLS – DIAGNOSIS, TREATMENT AND PSYCHOSOCIAL ASPECTS
Mayer–Rokitansky–Küster–Hauser (MRKH) syndrome is a rare congenital disorder characterized by agenesis or aplasia of the uterus and the upper part of the vagina in otherwise chromosomally and hormonally normal females (46,XX). It affects approximately 1 in 4500–5000 live female births and represents one of the most common causes of primary amenorrhea. Genetic and environmental factors are the main cause of the syndrome, although the pathogenesis is multifactorial. Diagnostics include both imaging tests (such as ultrasound or magnetic resonance imaging) and genetic tests. Therapeutic management is aimed at forming a functional neovagina that allows for comfortable sexual intercourse, achieved through either non-surgical dilation techniques or surgical vaginoplasty, selected according to the patient’s preferences and existing indications or contraindications to a given type of procedure. Available reproductive approaches, including uterine transplantation, surrogacy, and adoption, provide women with MRKH syndrome the possibility of achieving motherhood. Psychological assistance is essential, since the diagnosis has a significant impact on a woman’s self-esteem, perception of her body, and sense of sexual identity. Multidisciplinary care including medical, surgical, and psychological interventions is vital to achieving the best therapeutic outcomes and enhancing the quality of life of patients with MRKH syndrome.
- 24 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (4(48))
Open AccessMAYER-ROKITANSKY-KÜSTER-HAUSER (MRKH) SYNDROME IN GIRLS – DIAGNOSIS, TREATMENT AND PSYCHOSOCIAL ASPECTS
Mayer–Rokitansky–Küster–Hauser (MRKH) syndrome is a rare congenital disorder characterized by agenesis or aplasia of the uterus and the upper part of the vagina in otherwise chromosomally and hormonally normal females (46,XX). It affects approximately 1 in 4500–5000 live female births and represents one of the most common causes of primary amenorrhea. Genetic and environmental factors are the main cause of the syndrome, although the pathogenesis is multifactorial. Diagnostics include both imaging tests (such as ultrasound or magnetic resonance imaging) and genetic tests. Therapeutic management is aimed at forming a functional neovagina that allows for comfortable sexual intercourse, achieved through either non-surgical dilation techniques or surgical vaginoplasty, selected according to the patient’s preferences and existing indications or contraindications to a given type of procedure. Available reproductive approaches, including uterine transplantation, surrogacy, and adoption, provide women with MRKH syndrome the possibility of achieving motherhood. Psychological assistance is essential, since the diagnosis has a significant impact on a woman’s self-esteem, perception of her body, and sense of sexual identity. Multidisciplinary care including medical, surgical, and psychological interventions is vital to achieving the best therapeutic outcomes and enhancing the quality of life of patients with MRKH syndrome.
- Open Access
- 14 February 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 60, 34-43
Anatomical variations of artery of angular gyrus
Context: Angular gyrus is an anatomical structure of the brain located in the parietal lobe, taking part in writing and reading, language-use, memory and attention and spatial recognition. It is supplied by the angular gyrus artery, which is one of the caudal branches of the middle cerebral artery. One of the clinical pathologies of the angular gyrus artery is the ischemic stroke of the angular gyrus in the dominant hemisphere, responsible for the presence of Gerstmann Syndrome: left-right disorientation, agraphia, alexia, acalculia and finger agnosia. This systematic review aims to present the variety of anomalies of the main cerebral artery and the angular gyrus artery. Objective: Preparing a systematic review of papers describing the course anomalies of the angular gyrus artery. Materials and methods: PubMed and Google Scholar electronic databases was searched for phrases: ‘Angular gyrus artery’, ‘Artery of angular gyrus’, ‘Middle cerebral artery branches’, ‘Branches of middle cerebral artery’, ‘Gerstmann Syndrome’ published between years 2015 and 2023. Also 3 papers published before 2000 were used. From the selected 30 papers, 6 were used to prepare this analysis. Results: The middle cerebral artery, from which arises the angular gyrus artery, is marked by a significant variety of its division, mainly the number of the dividing trunks of the artery. Depending on the type of the division, the angular gyrus artery can arise from the upper, middle or lower trunk and vary in sizes. It can also appear as a singular or two separate branches. Instances of the anomaly of both the angular gyrus artery and posterior parietal artery are rare, but reported. Conclusions: The angular gyrus artery is characterised by a number of anomalies in its course, separation from the middle cerebral artery, diameter and branching.
- 14 February 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 60, 34-43
Open AccessAnatomical variations of artery of angular gyrus
Context: Angular gyrus is an anatomical structure of the brain located in the parietal lobe, taking part in writing and reading, language-use, memory and attention and spatial recognition. It is supplied by the angular gyrus artery, which is one of the caudal branches of the middle cerebral artery. One of the clinical pathologies of the angular gyrus artery is the ischemic stroke of the angular gyrus in the dominant hemisphere, responsible for the presence of Gerstmann Syndrome: left-right disorientation, agraphia, alexia, acalculia and finger agnosia. This systematic review aims to present the variety of anomalies of the main cerebral artery and the angular gyrus artery. Objective: Preparing a systematic review of papers describing the course anomalies of the angular gyrus artery. Materials and methods: PubMed and Google Scholar electronic databases was searched for phrases: ‘Angular gyrus artery’, ‘Artery of angular gyrus’, ‘Middle cerebral artery branches’, ‘Branches of middle cerebral artery’, ‘Gerstmann Syndrome’ published between years 2015 and 2023. Also 3 papers published before 2000 were used. From the selected 30 papers, 6 were used to prepare this analysis. Results: The middle cerebral artery, from which arises the angular gyrus artery, is marked by a significant variety of its division, mainly the number of the dividing trunks of the artery. Depending on the type of the division, the angular gyrus artery can arise from the upper, middle or lower trunk and vary in sizes. It can also appear as a singular or two separate branches. Instances of the anomaly of both the angular gyrus artery and posterior parietal artery are rare, but reported. Conclusions: The angular gyrus artery is characterised by a number of anomalies in its course, separation from the middle cerebral artery, diameter and branching.